Concepedia

Taylor A. Gentile

TA

Statistics

Publications

9

Citations

378

H-Index

9

Active since

2013

Affiliations

Temple University(Current)

National Institutes of Health

Fox Chase Chemical Diversity Center

National Institute on Drug Abuse

Taylor A. Gentile is an author at Temple University specializing in pharmacology, neuropharmacology, and addiction.

Publications per year

2013–2022

9

Publications

9

Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion

Jeffrey J. Liu, Yi-Ting Chiu, Kelly M. DiMattio et al. · Neuropsychopharmacology · 2018 · 95 citations · Full text

, , +15

Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine

Taylor A. Gentile, Steven J. Simmons, David J. Barker et al. · Addiction Biology · 2017 · 78 citations

, , +17

Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine

Taylor A. Gentile, Mia N. Watson, Krista L. Connelly et al. · Neuropsychopharmacology · 2017 · 69 citations

, , +13

Synthesis, structure, physicochemical characterization and electronic structure of thio-lithium super ionic conductors, Li4GeS4 and Li4SnS4

Joseph H. MacNeil, Danielle M. Massi, Jian‐Han Zhang et al. · Journal of Alloys and Compounds · 2013 · 36 citations

, , +16

Comparing rewarding and reinforcing properties between ‘bath salt’ 3,4‐methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats

Steven J. Simmons, Ryan A. Gregg, Fionya H. Tran et al. · Addiction Biology · 2016 · 29 citations

, , +17

1–5 of 9